Raymond Hill has been appointed executive vice president of Clinical at inVentiv Health, Inc. Mr. Hill will be responsible for leading the company’s Clinical business segment, which includes Early Stage, Phase II-IV and Strategic Resourcing.
 
Prior to joining the company, he served as chief executive officer at PPD, where he oversaw the process of taking the company private. Prior to that, he was president at IMS Consulting Group, and held a series of positions in pharmaceutical consulting.
 
“We are very pleased to welcome a seasoned industry veteran like Ray to inVentiv and expect that his significant experience in both successfully growing pharmaceutical services businesses and leading productive teams will be an asset to our organization,” said Paul Meister, chief executive officer at inVentiv.